​

ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?


OverviewForecastFinancialsChart

ORIC Pharmaceuticals Ownership Summary


ORIC Pharmaceuticals is owned by 109.80% institutional investors, 1.69% insiders. Nextech invest is the largest institutional shareholder, holding 7.49% of ORIC shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.86% of its assets in ORIC Pharmaceuticals shares.

ORIC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockORIC Pharmaceuticals109.80%1.69%-11.49%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nextech invest5.29M7.49%$42.66M
Blackrock4.83M7.17%$34.15M
Nextech invest7.16M6.79%$77.57M
Blackrock funding, inc. /de6.98M6.46%$94.01M
Ecor1 capital6.73M6.38%$72.87M
Price t rowe associates inc /md/6.62M6.27%$71.67M
Viking global investors lp5.13M4.86%$55.52M
Vanguard group4.54M4.59%$37.15M
Sr one capital management, lp4.62M4.38%$49.98M
Vr adviser4.32M4.10%$46.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Column group3.54M43.53%$38.35M
Invus financial advisors1.01M7.98%$7.12M
Nextech invest5.29M6.92%$42.66M
Sr one capital management, lp4.62M4.81%$49.98M
Nextbio capital management lp684.48K3.93%$9.22M
Nextech invest7.16M3.68%$77.57M
Ecor1 capital6.73M3.54%$72.87M
Pfizer372.90K2.99%$4.91M
Nea management company4.12M2.81%$44.60M
Superstring capital management lp406.08K2.78%$4.40M

Top Buyers

HolderShares% AssetsChange
Blackrock4.83M0.00%1.65M
D. e. shaw1.58M0.01%1.54M
Price t rowe associates inc /md/6.62M0.01%1.23M
Algert global1.22M0.16%1.08M
Goldman sachs group2.45M0.00%976.08K

Top Sellers

HolderShares% AssetsChange
Point72 asset management---2.92M
Commodore capital lp---2.00M
Paradigm biocapital advisors lp---1.70M
Avidity partners management lp---1.27M
Frazier life sciences management---1.07M

New Positions

HolderShares% AssetsChangeValue
Two sigma investments, lp603.66K0.00%603.66K$6.54M
Zweig-dimenna associates268.79K0.28%268.79K$3.62M
Driehaus capital management148.78K0.01%148.78K$1.79M
Walleye capital63.08K0.00%63.08K$849.67K
Caption management48.13K0.00%48.13K$521.25K

Sold Out

HolderChange
Capital performance advisors llp-1.00
Nelson, van denburg & campbell wealth management group-8.00
Stone house investment management-18.00
Coldstream capital management-45.00
Covestor-48.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202621212.17%118,593,940-4.54%1090.79%1205.26%5527.91%
Jun 30, 20261871.08%124,132,3864.00%1170.92%11214.29%43-31.75%
Mar 31, 20261819.04%114,725,898-4.12%1300.89%94-7.84%6477.78%
Dec 31, 202556-63.87%20,254,766-80.98%200.11%33-63.74%16-52.94%
Sep 30, 202552-62.04%16,331,312-82.02%200.15%33-54.17%13-74.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest2.96M2.86%-
Vanguard Total Stock Mkt Idx Inv2.92M2.82%180.40K
Vanguard Morn Total Stk Mkt Idx Investor2.92M2.82%180.40K
Vanguard US Total Market Shares ETF1.88M2.65%-
State Street® SPDR® S&P® Biotech ETF2.59M2.50%67.89K
iShares Russell 2000 ETF1.88M1.82%-
Fidelity Growth Compy Commingled Pl O1.28M1.81%-
ACAP Strategic A1.85M1.79%-375.60K
Fidelity Growth Compy Commingled Pl S1.32M1.28%-
T. Rowe Price Integrated US SmCapGrEq1.26M1.22%311.10K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 20, 2026Piscitelli Dominic Chief Financial OfficerSell$189.39K
Oct 01, 2026Heyman Richard A.-Sell$45.20K
Oct 01, 2026Heyman Richard A.-Sell$41.33K
Sep 28, 2026Piscitelli Dominic Chief Financial OfficerSell$181.26K
Sep 24, 2026Piscitelli Dominic Chief Financial OfficerSell$1.35K

Insider Transactions Trends


DateBuySell
2026 Q4-3
2026 Q3-7
2026 Q1-3
2025 Q4-6
2025 Q3-3

ORIC Ownership FAQ


Who Owns ORIC Pharmaceuticals?

ORIC Pharmaceuticals shareholders are primarily institutional investors at 109.80%, followed by 1.69% insiders and -11.49% retail investors. The average institutional ownership in ORIC Pharmaceuticals's industry, Biotech Stocks , is 181.71%, which ORIC Pharmaceuticals falls below.

Who owns the most shares of ORIC Pharmaceuticals?

ORIC Pharmaceuticals’s largest shareholders are Nextech invest (5.29M shares, 7.49%), Blackrock (4.83M shares, 7.17%), and Nextech invest (7.16M shares, 6.79%). Together, they hold 21.46% of ORIC Pharmaceuticals’s total shares outstanding.

Does Blackrock own ORIC Pharmaceuticals?

Yes, BlackRock owns 7.17% of ORIC Pharmaceuticals, totaling 4.83M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.15M$. In the last quarter, BlackRock increased its holdings by 1.65M shares, a 52.00% change.

Who is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Column group is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 43.53% of its assets in 3.54M ORIC Pharmaceuticals shares, valued at 38.35M$.

Who is the top mutual fund holder of ORIC Pharmaceuticals shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of ORIC Pharmaceuticals shares, with 2.86% of its total shares outstanding invested in 2.96M ORIC Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools